Skip to main content

Table 2 Results platelet activation

From: Platelets of patients with chronic kidney disease demonstrate deficient platelet reactivity in vitro

 

Controls

CKD

P-value

P-value

 

N = 19

N = 23

 

Adjusted for age

Maximal MFI TRAP, AU (IQR)

11.4 (9.2-12.2)

9.7 (7.9-10.8)

0.032

0.095

Maximal MFI ADP, AU (IQR)

2.6 (1.9-3.5)

1.6 (1.2-2.1)

0.002

0.004

Maximal MFICRP, AU (IQR)

11.5 (9.5-12.9)

9.2 (8.5-10.8)

0.004

0.010

EC50 TRAP, μM (IQR)

1.9 (1.5-2.5)

2.3 (1.8-2.6)

0.372

0.182

EC50 ADP, μM (IQR)

0.9 (0.6-1.1)

0.89 (0.7-1.1)

0.544

0.597

EC50 CRP, ng/ml (IQR)

120 (46.7-312.7)

116.1 (46.1-270.5)

0.955

0.660

AUC TRAP, AU (IQR)

47.1 (41.1-54.2)

39.5 (32.9-44.4)

0.012

0.023

AUC ADP, AU (IQR)

8.9 (7.9-12.2)

5.8 (3.8-7.3)

0.002

0.003

AUC CRP, AU (IQR)

30.3 (22.1-41.9)

23.4 (18.9-34.7)

0.063

0.322

  1. MFI Mean fluorescence intensity, AU arbitrary units, IQR inter quartile range, EC50 concentration of agonist leading to a half maximal P-selectin expression, AUC Area under the curve.